The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Phospholipase A2 Receptor Autoantibodies and Clinical Outcome in Patients with Primary Membranous Nephropathy
Open accessAbstract
Membranous nephropathy (MN) is the most common cause of nephrotic syndrome in adults, with an uncertain clinical outcome. The characterization of the phospholipase A2 receptor (PLA2R) as the major target antigen in primary MN and the detection of circulating autoantibodies in these patients is a major advance in understanding this disease. To test whether PLA2R antibody levels reflect disease activity or clinical outcome, we performed a prospective multicenter study of 133 adult patients with primary MN and detectable serum PLA2R antibodies who had not received immunosuppressive therapy. Patients were followed ≤24 months. PLA2R antibody levels associated with clinical disease activity (proteinuria) in patients with immunosuppressive therapy (n=101) or supportive care (n=32). Within 3 months, immunosuppressive therapy led to a sustained 81% reduction in PLA2R antibody levels paralleled by a 39% reduction in proteinuria. Patients who experienced remission of proteinuria after 12 months had significantly lower PLA2R antibody levels at the time of study inclusion compared with patients with no remission. Patients with high PLA2R antibody levels achieved remission of proteinuria significantly later than patients with low PLA2R antibody levels. PLA2R antibody levels fell over time in patients with spontaneous remission but remained elevated in patients who did not show a reduction in proteinuria. Multivariable Cox regression analysis confirmed PLA2R antibody level as an independent risk factor for not achieving remission of proteinuria. We conclude that a decrease in PLA2R antibody level is associated with a decrease of proteinuria in patients with primary MN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
M-Type Phospholipase A 2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy
Beck, L. H., Bonegio, R. G. B., Lambeau, G., Beck, D. M., Powell, D. W., Cummins, T. D., Klein, J. B., & Salant, D. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810457 · Cited by 2,347
Faul, C., Donnelly, M., Merscher-Gomez, S., Chang, Y. H., Franz, S., Delfgaauw, J., Chang, J.-M., Choi, H. Y., Campbell, K. N., Kim, K., et al. (2008) · Nature Medicine · doi:10.1038/nm.1857 · Cited by 991
Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy
Beck, L. H., Fervenza, F. C., Beck, D. M., Bonegio, R. G. B., Malik, F. A., Erickson, S. B., Cosio, F. G., Cattran, D. C., & Salant, D. J. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111125 · Cited by 471
Prognosis of Untreated Patients with Idiopathic Membranous Nephropathy
Schieppati, A., Mosconi, L., Perna, A., Mecca, G., Bertani, T., Garattini, S. K., & Remuzzi, G. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307083290203 · Cited by 430
Ponticelli, C., Altieri, P., Scolari, F., Passerini, P., Roccatello, D., Cesana, B., Melis, P., Valzorio, B., Sasdelli, M., Pasquali, S., et al. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v93444 · Cited by 389
Kanigicherla, D., Gummadova, J., McKenzie, E. A., Roberts, S. A., Harris, S., Nikam, M., Poulton, K., McWilliam, L., Short, C. D., Venning, M., et al. (2013) · Kidney International · doi:10.1038/ki.2012.486 · Cited by 347
Antiphospholipase A2 Receptor Antibody Titer and Subclass in Idiopathic Membranous Nephropathy
Hofstra, J. M., Debiec, H., Short, C. D., Pellé, T., Kleta, R., Mathieson, P. W., Ronco, P., Brenchley, P. E., & Wetzels, J. F. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012030242 · Cited by 321
Cattran, D. C., Pei, Y., Greenwood, C. M. T., Ponticelli, C., Passerini, P., & Honkanen, E. (1997) · Kidney International · doi:10.1038/ki.1997.127 · Cited by 229
Dähnrich, C., Komorowski, L., Probst, C., Seitz‐Polski, B., Esnault, V. L. M., Wetzels, J. F. M., Hofstra, J. M., Hoxha, E., Stahl, R. A. K., Lambeau, G. J., et al. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.03.015 · Cited by 138
Self-citation
Cited by
Angeletti, A., Migliorini, P., Bruschi, M., Pratesi, F., Candiano, G., Prunotto, M., Verrina, E., & Ghiggeri, G. M. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102977 · Cited by 18
Metadata
- Authors
- Hoxha, E., Thiele, I., Zahner, G., Panzer, U., Harendza, S., & Stahl, R. A. K.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2014-06
- Volume
- 25
- Issue
- 6
- Pages
- 1357-1366
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2097148864
- Cited by
- 353
- References
- 9
- FWCI
- 24.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phospholipase A2 Receptor Autoantibodies and Clinical Outcome in Patients with Primary Membranous Nephropathy. https://app.cochat.ai/papers/10.1681/asn.2013040430
- The paper
- Hoxha, E., Thiele, I., Zahner, G., Panzer, U., Harendza, S., & Stahl, R. A. K. (2014). Phospholipase A2 Receptor Autoantibodies and Clinical Outcome in Patients with Primary Membranous Nephropathy. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2013040430
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.